2W3O
Crystal structure of the human PNKP FHA domain in complex with an XRCC1-derived phosphopeptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04 |
Synchrotron site | Diamond |
Beamline | I04 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-08-04 |
Detector | ADSC QUANTUM 315 |
Spacegroup name | P 3 |
Unit cell lengths | 56.900, 56.900, 62.770 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 62.750 - 1.850 |
R-factor | 0.181 |
Rwork | 0.178 |
R-free | 0.23600 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2brf |
RMSD bond length | 0.018 |
RMSD bond angle | 1.720 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.4.0066) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 38.750 | 1.950 |
High resolution limit [Å] | 1.850 | 1.850 |
Rmerge | 0.070 | 0.300 |
Number of reflections | 19211 | |
<I/σ(I)> | 5.78 | 2.43 |
Completeness [%] | 99.0 | 95.3 |
Redundancy | 3.37 | 2.12 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | 0.1 M TRIS-HCL PH 8.5, 0.25 M CACL2, 28% W/V PEG 4000, 0.2 M NDSB-221 |